About the SEER Program (2024)

FAQs

About the SEER Program? ›

The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population.

The SEER Program provides information on cancer statistics to help reduce the cancer burden among the US population. SEER has been funded by the NCI since 1973.

Participating sites include: (1) twelve states with central cancer registries: Connecticut, Georgia, Hawaii, Idaho, Iowa, Kentucky, Louisiana, Massachusetts, New Jersey, New Mexico, New York, and Utah; and (2) four metropolitan, multi-county areas: (Greater California, Los Angeles, and Greater Bay Area -- San Francisco ...

The SCCCR uses the SEER General Summary Staging System. This system includes five stages: in situ, localized, regional, distant, and unstaged. In situ and localized are classified as "early stage." Regional and distant are considered "late stage." Cancers diagnosed as in situ are considered pre-invasive.

About SEER

SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 48.0 percent of the U.S. population.

SEER collects data on cancer cases from various locations and sources throughout the United States. Data collection began in 1973 with a limited number of registries and continues to expand to include even more areas and demographics today. What is a Cancer Registry?

SEER collects and publishes cancer data from a set of 17 population-based regional cancer registries located throughout the country. Who provides the data set? National Cancer Institute.

Stage 4 cancer usually has spread to multiple places in the body, meaning you can live only a few weeks or a few months. In rare cases, some people may survive for several months or even a year with stage 4 cancer, with or without treatment.

Cancer is typically labeled in stages from I to IV, with IV being the most serious. Those broad groups are based on a much more detailed system that includes specific information about the tumor and how it affects the rest of your body.

Breast cancer survival & mortality statistics

The 5-year relative survival rate in the U.S. for all types and stages of breast cancer combined is 91%. The 5-year relative survival rate in the U.S. of localized (early stage) breast cancer is 99%.

How many patients are in the SEER database? ›

Prioritizing your needs and knowing what to look for will help you find the perfect air conditioner for your home. Most homeowners opt for a unit with a SEER rating between 15 and 18. This is because it provides a good balance between the upfront cost of the unit and the amount you'll save on your utility bills.

The Prototype Fund is a funding program of the Federal Ministry of Education and Research (BMBF) that is supported and evaluated by the Open Knowledge Foundation Germany.

Information about Cancer Statistics

Because these areas are representative of the demographics of the entire U.S. population, SEER is able to account for diverse populations throughout the U.S. SEER also reports mortality data, which are provided by the National Center for Health Statistics.

One of the goals of the NIH is to "expand the base in medical and associated sciences in order to ensure a continued high return on the public investment in research." Taxpayer dollars funding NIH are from the taxpayers, making them the primary beneficiaries of advances in research.

Seer Data's standard plan gets you started accessing and analysing data for free.